Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
0.770
+0.030 (3.99%)
At close: Nov 4, 2024, 4:00 PM
0.750
-0.019 (-2.53%)
After-hours: Nov 4, 2024, 4:35 PM EST
Company Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.
It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Akanda Corp.
| Country | United Kingdom |
| Founded | 2021 |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Katharyn Field |
Contact Details
Address: 1a, 1b Learoyd Road New Romney, TN28 8XU United Kingdom | |
| Phone | 44 20 2498 7917 |
| Website | akandacorp.com |
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M106 |
| ISIN Number | CA00971M2058 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer and Executive Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2024 | 6-K | Report of foreign issuer |
| Oct 4, 2024 | 6-K | Report of foreign issuer |
| Oct 3, 2024 | 424B4 | Prospectus |
| Oct 2, 2024 | 6-K | Report of foreign issuer |
| Sep 30, 2024 | EFFECT | Notice of Effectiveness |
| Sep 20, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 16, 2024 | 6-K | Report of foreign issuer |
| Sep 5, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Jul 25, 2024 | 6-K | Report of foreign issuer |
| Jun 14, 2024 | 6-K | Report of foreign issuer |